Adjuvant pembrolizumab for postnephrectomy renal cell carcinoma (RCC): Expanded efficacy analyses from KEYNOTE-564.

Choueiri, TK; Tomczak, P; Park, SH; Venugopal, B; Ferguson, T; Symeonides, SN; Hajek, J; Chang, YH; Lee, JL; Sarwar, N; Thiery-Vuillemin, A; Gross-Goupil, M; Mahave, M; Haas, NB; Sawrycki, P; Gurney, H; Xu, L; Imai, K; Rogerio, J; Powles, T

JOURNAL OF CLINICAL ONCOLOGY, 2022; 40 (16):

Abstract

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索